Supplementary Figure 1 from A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

Authors :: Marina Konopleva
Deborah Thomas
Linda J. Bendall
Jan Burger
Susan O'Brien
Elias Jabbour
Keith A. Baggerly
Wenbin Liu
Lianchun Xiao
Rebecca Garris
Mary Ann Richie
Hongbo Lu
Zhihong Zeng
Kirk S. Culotta
Jordan Basnett
Jitesh D. Kawedia
Michael E. Rytting
Jorge Cortes
Farhad Ravandi
Hagop Kantarjian
Yanis Boumber
Naval Daver
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figure 1.Baseline 4EBP1 and outcomes.

Tools